Genital herpes

DW Kimberlin, DJ Rouse - New England Journal of Medicine, 2004 - Mass Medical Soc
A 22-year-old woman presents to her gynecologist with genital lesions. Examination reveals
bilateral labial ulcerations, cervical ulcerations, and mildly tender inguinal …

Review of whole plant extracts with activity against herpes simplex viruses in vitro and in vivo

A Garber, L Barnard, C Pickrell - Journal of evidence-based …, 2021 - journals.sagepub.com
Herpes simplex viruses, HSV-1 and HSV-2, are highly contagious and cause lifelong, latent
infections with recurrent outbreaks of oral and/or genital lesions. No cure exists for HSV-1 or …

Estimation of the impact of genital warts on health-related quality of life

S Woodhall, T Ramsey, C Cai, S Crouch, M Jit… - Sexually transmitted …, 2008 - sti.bmj.com
Objectives: One of the two new human papillomavirus (HPV) vaccines protects against HPV
types 6 and 11, which cause over 95% of genital warts, in addition to protecting against HPV …

Estimated economic burden of genital herpes and HIV attributable to herpes simplex virus type 2 infections in 90 low-and middle-income countries: A modeling study

S Silva, HH Ayoub, C Johnston, R Atun… - PLoS …, 2022 - journals.plos.org
Background Economic losses due to herpes simplex infections in low-and middle-income
countries (LMICs) are unknown. We estimated economic and quality-of-life losses due to …

Contriving a chimeric polyvalent vaccine to prevent infections caused by herpes simplex virus (type-1 and type-2): an exploratory immunoinformatic approach

M Hasan, S Islam, S Chakraborty… - Journal of …, 2020 - Taylor & Francis
Herpes simplex virus type 1 (HSV-1) and 2 (HSV-2) cause a variety of infections including
oral-facial infections, genital herpes, herpes keratitis, cutaneous infection and so on. To …

Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs

N Bourne, FJ Bravo, M Francotte… - The Journal of …, 2003 - academic.oup.com
In two recent clinical trials, a vaccine containing herpes simplex virus (HSV) type 2
glycoprotein D (gD2) and a novel adjuvant AS04 comprising alum (Al) and 3-deactylated …

Sexually transmissible infections other than HIV

B Donovan - The Lancet, 2004 - thelancet.com
Sexually transmitted infections (STIs) are notable for their fastidious requirements for
transmission and growth in the laboratory and for their high physical and psychosocial …

Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit

E Girou, S Chevaliez, D Challine… - Clinical infectious …, 2008 - academic.oup.com
Background. Nosocomial transmission is the second most frequent cause of hepatitis C virus
(HCV) infection. A prospective observational study was conducted to assess the roles of …

A meta-analysis to assess the efficacy of oral antiviral treatment to prevent genital herpes outbreaks

B Lebrun-Vignes, A Bouzamondo, A Dupuy… - Journal of the American …, 2007 - Elsevier
BACKGROUND: Efficacy of oral antiviral therapies, ie, acyclovir, valacyclovir (VACV), and
famciclovir, for suppression of recurrent genital herpes was studied at different doses and …

[HTML][HTML] Vaccine value profile for herpes simplex virus

C Johnston, S Scheele, L Bachmann, MC Boily… - Vaccine, 2024 - Elsevier
Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are chronic, highly prevalent viral
infections that cause significant morbidity around the world. HSV-2 is sexually transmitted …